About PPX
The question for this industry is no longer how to make it legal. It is how to compete and grow in newly legal markets. PPX was built for that second question.
PPX exists at the intersection of strategy, creative and institutional access. We're part of Prohibition Partners — the organisation that has tracked, analysed and shaped the global cannabis industry for a decade.
Our clients don't just get campaigns. They get proprietary market intelligence, direct introductions to investors and operators, visibility through the world's largest B2B cannabis media network, and strategic guidance informed by regulatory insight across every major market.
We turn that platform into commercial outcomes: faster launches, smarter positioning, stronger networks, measurable growth.
The platform
Four brands most agencies would call a media buy.
We call it the office.
- The intelligence house
A decade of market data, regulatory tracking and published research — the evidence base under every engagement. - The news wire
The industry's business press on both sides of the Atlantic — the journalists covering the sector seriously. - The rooms
Europe's leading industry summit — where operators, investors and policymakers actually meet. - The patient title
The UK's patient-side journalism — the view from the demand side of medical markets.
How we work
- 01Intelligence-informed strategyPositioning and market-entry decisions grounded in Prohibition Partners' proprietary data, not agency instinct.
- 02Compliant executionMessaging reviewed against current regulation before it ships. Companies that communicate effectively within the rules have an edge over those that can't.
- 03Introductions that compress timelinesDirect routes to the investors, operators and clinicians who move a market — because we've spent a decade in the same rooms.
Full team and advisory leadership to follow — announcements land here as contracts are signed, not before.